Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Specific KIR-HLA genotypes predict outcomes in refractory or relapsed primary central nervous system lymphoma.

Hematology (Amsterdam, Netherlands) - 1 Dec 2023

Lin Zhiguang, Xu Huiwen, Ma Jingjing, Ma Yan, Li Qing, Kang Hui, Zhang Mengxue, Chen Bobin

Abstract excerpt

INTRODUCTION: An effective salvage regimen for the reinduction of remission is lacking for refractory or relapsed primary central nervous system lymphoma (r/r PCNSL). This study aimed to evaluate the efficacy and safety of cytarabine plus temozolomide in treating r/r PCNSL and to explore the associated prognostic factors. METHODS: A single-center retrospective cohort study was conducted to assess the efficacy and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Central Nervous System

Share to Central Nervous System Neoplasms

Share to Cytarabine

Share to HLA-B Antigens

Share to Lymphoma, Non-Hodgkin

Share to Temozolomide

Source

Identifiers

PMID: 37545411
DOI: 10.1080/16078454.2023.2243424

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Specific KIR-HLA genotypes predict outcomes in refractory or relapsed primary central nervous system lymphoma.PMID 37545411Read ↗

Specific KIR-HLA genotypes predict outcomes of refractory or recurrent primary central nervous system lymphomaSemantic proximity Read ↗

Specific KIR-HLA genotypes predict the outcomes of refractory or recurrent primary central nervous system lymphomaSemantic proximity Read ↗

Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in TreatmentSemantic proximity Read ↗

Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.Semantic proximity Read ↗

Primary Central Nervous System Lymphoma: Evolving Biologic Insights and Recent Therapeutic Advances.Semantic proximity Read ↗

Genomic landscape and molecular subtypes of primary central nervous system lymphoma.Semantic proximity Read ↗

Patient's HLA Genotype Is Associated With the Risk of Central Nervous System Dissemination and Clinical Disease Presentation in Diffuse Large B-cell Lymphoma.Semantic proximity Read ↗

Efficacy of BTK inhibitor administered for central high-risk systemic diffuse large B cell lymphoma and primary central nervous system lymphoma: A single-center retrospective studySemantic proximity Read ↗

Insights into the biology of primary central nervous system lymphoma.Semantic proximity Read ↗

Primary CNS lymphoma commonly expresses immune response biomarkersSemantic proximity Read ↗

The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signalingSemantic proximity Read ↗

Allogeneic HSCT Improves Prognosis in Advanced Extranodal NK/T-Cell LymphomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.